BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32324290)

  • 1. Aggressive B-cell lymphomas with a primary bone marrow presentation.
    Zamò A; Johnston P; Attygalle AD; Laurent C; Arber DA; Fend F
    Histopathology; 2020 Sep; 77(3):369-379. PubMed ID: 32324290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathologic spectrum of mature aggressive B cell lymphomas.
    Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Facchetti F; Pileri S; Rosenwald A; Wotherspoon A; Fend F
    Virchows Arch; 2017 Oct; 471(4):453-466. PubMed ID: 28844114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens.
    Kim H; Kim HJ; Kim SH
    Ann Lab Med; 2020 Sep; 40(5):361-369. PubMed ID: 32311849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
    Porwit A; Fend F; Kremer M; Orazi A; Safali M; van der Walt J
    Histopathology; 2016 Sep; 69(3):349-73. PubMed ID: 27208429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
    Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop.
    Duffield AS; Dogan A; Amador C; Cook JR; Czader M; Goodlad JR; Nejati R; Xiao W; Happ L; Parker C; Thacker E; Thakkar D; Dave SS; Wasik MA; Ott G
    Am J Clin Pathol; 2023 May; 159(6):572-97. PubMed ID: 37167543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
    Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
    Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.
    de Jong D; Roemer MG; Chan JK; Goodlad J; Gratzinger D; Chadburn A; Jaffe ES; Said J; Natkunam Y
    Am J Clin Pathol; 2017 Feb; 147(2):153-170. PubMed ID: 28395108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution.
    Allory Y; Challine D; Haioun C; Copie-Bergman C; Delfau-Larue MH; Boucher E; Charlotte F; Fabre M; Michel M; Gaulard P
    Am J Surg Pathol; 2001 Jul; 25(7):865-74. PubMed ID: 11420457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.
    Ott G
    Br J Haematol; 2017 Sep; 178(6):871-887. PubMed ID: 28748558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
    Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
    Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Zamò A; van den Brand M; Climent F; de Leval L; Dirnhofer S; Leoncini L; Ng SB; Ondrejka SL; Quintanilla-Martinez L; Soma L; Wotherspoon A
    Virchows Arch; 2023 Sep; 483(3):317-331. PubMed ID: 37656249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification.
    Ok CY; Medeiros LJ
    Pathology; 2020 Jan; 52(1):68-77. PubMed ID: 31735344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.